Results 91 to 100 of about 1,796 (202)
Zhongguo shiyan zhenduanxue, 2017 母细胞性浆细胞样树突状细胞肿瘤（blastic plasmacytoid dendritic cell neoplasm,BPDCN）是一种罕见的血液系统恶性肿瘤,易侵犯皮肤和骨髓,目前的诊断还没有完全特征性的指标,治疗上亦无标准有效的治疗手段。BPDCN的发病以老年人居多,现总结我科收治的1例青年男性BPDCN患者临床资料,并结合国内外报道的BPDCN病例,回顾性分析患者的临床特征,提高临床医生对BPDCN的诊疗水平。1病例资料患者,男性,25岁 ...
刘芳 +5 more
doaj
eJHaemBlastic plasmacytoid dendritic cell neoplasm (BPDCN) predominantly occurs in adults ≥60 years old; 10–20% of cases are pediatric or adolescent/young adult (AYA) patients.
Naveen Pemmaraju +11 more
doaj +1 more source
Detection of Hematological Malignancies Using N‐NOSE (Nematode‐NOSE)
Hematological Oncology, Volume 43, Issue 3, May 2025.ABSTRACT Hematological malignancies often lack defined risk factors and present with non‐specific symptoms, underscoring the urgent need for simple and reliable detection methods. To address this challenge, Hirotsu et al. innovated N‐NOSE, a novel, non‐invasive cancer screening test that utilizes the chemotaxis response of the nematode Caenorhabditis ...
Shingen Nakamura +6 more
wiley +1 more source
Cell Proliferation, Volume 58, Issue 4, April 2025.This manuscript provides a comprehensive overview of the state‐of‐the‐art in non‐viral CAR‐NK cell engineering, highlighting its potential to revolutionise cancer treatment. ABSTRACT The recent advancements in cancer immunotherapy have spotlighted the potential of natural killer (NK) cells, particularly chimeric antigen receptor (CAR)–transduced NK ...
Zhaokai Zhou +18 more
wiley +1 more source
Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms [PDF]
Aims: The discovery of somatic genetic alterations established many histiocytic disorders as haematologic neoplasms. We aimed to investigate the demographic characteristics and additional haematologic cancers of patients diagnosed with histiocytic ...
Bruggink, Annette H. +11 more
core +4 more sources
A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients
Therapeutic Advances in HematologyBackground: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematological cancer. Due to its low incidence, researchers struggle to gather sufficient prospective data to inform clinical treatment.
Chen Gong, Ying Liu, Mingzhi Zhang
doaj +1 more source
American Journal of Hematology, Volume 100, Issue 8, Page 1432-1433, August 2025.
Romain Ravel‐Chapuis +7 more
wiley +1 more source
OncoLog, Volume 60, Number 10, October 2015 [PDF]
, 2015 New Targeted Therapy Offers Hope to Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, Related Diseases: The treatment of common hematological malignancies is based on reams of study data and years of physician experience with the diseases.
Deisigne, Jill +3 more
core
A Case Report of Tragaxofusp Causing Severe Tumor Lysis Syndrome In A Patient With Blastic Plasmacytoid Dendritic Cell Neoplasm [PDF]
, 2020 The patient was an 83-year-old male without significant past medical hsitory who presented to his primary care physician with several days of generalized ...
Lin, MD, Shuwen, Wang, MD, Alice
core +1 more source
Innate immune modulation by GM-CSF and IL-3 in health and disease [PDF]
, 2019 Granulocyte-macrophage colony-stimulating factor (GM-CSF) and inteleukin-3 (IL-3) have long been known as mediators of emergency myelopoiesis, but recent evidence has highlighted their critical role in modulating innate immune effector functions in mice ...
Borriello F. +5 more
core +1 more source